Skip to main content

November 2016

 

 

academics

 

Clinical research courses

Quality Control walk-in at Cadila Pharmaceuticals Ltd | Only experienced candidates

Cadila Pharmaceuticals Ltd. (CPL) is one of India's most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its corporate office at Bhat, Ahmedabad and State-Of-Art manufacturing facilities compliant with USFDA, MHRA, TGA, MCA, MCC & WHO norms at Dholka, Ankleshwar, Kadi and Jammu.

Post : Quality Control - Sr Officer / Executive / AM /DM

Opening for Senior Safety Processing Expert at Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Senior Safety Processing Expert

Job as Director Quality Operations – ETHICON at Johnson & Johnson

Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices markets. Johnson & Johnson strives to provide scientifically sound, high quality products and services to help heal, cure disease and improve the quality of life. The organization is comprised of more than 275 operating companies in more than 60 countries employing approximately 128,700 employees. With Global sales of USD $74.3 billion in 2014, Johnson & Johnson is recognized as one of the most admired and respected companies in the world. Johnson & Johnson companies are equal opportunity employers.

Post : Director Quality Operations – ETHICON

A NOTE ON NEPHELO-TURBIDIMETRIC ANALYSIS

{ DOWNLOAD AS PDF }

 

ABOUT AUHTOR
Deepak Chowrasia* Dr. Nisha Sharma
University Institute of Pharmacy, CSJM University,
Kanpur, U.P.-208024, India
*chowrasia.deepak@gmail.com

ABSTRACT
The article describes here some of the aspects of scattering of light and its applicability in Nephelo-turbidimetric analysis.

International Society for Pharmacoeconomics and Outcomes Research ISPOR India –Andhra Pradesh Regional Chapter in association with Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu, Andhra Pradesh; Rural Development Trust (RDT) Hospital, Anantapuramu, Andhra Pradesh and Indian Pharmaceutical Association (IPA) Anantapuramu Local Branch organized One Day National Symposium on “Innovations in Pharmacovigilance for ensuring Drug Safety and ensuring Life” on 24th November 2016 (Thursday)  at A.C auditorium, Rural Development Trust (RDT) Hospital, Anantapuramu, Andhra Pradesh.

Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu, Andhra Pradesh in association with Priyadarshini Institute of Pharmaceutical Education and Research, Guntur. Andhra Pradesh organized a Two Days National Workshop on Advances in Pharmacy Practice: Series of Educational and Training Module by faculties of Division of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER).  The workshop drew around 60 Pharm. D students, which focussed on Patient care and the role of Pharmacists in healthcare system on policy and practice perspective.

(adsbygoogle = window.adsbygoogle || []).push({});
Career for Masters in Pharmaceuticals at NIPER | salary of Rs.80,000/- per month.

National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar (Mohali), Punjab under the aegis of Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), Govt. of India, is an autonomous institute of National Importance created by an Act of Parliament devoted to the promotion of pharmaceutical education and research. The Institute is located at SAS Nagar (Ajitgarh), adjoining the beautiful city of Chandigarh. It is ideally placed for intellectual interaction with the several medical, scientific and technological centers. The Institute has a pleasing campus with fully equipped laboratories and instructional facilities and necessary housing provision.

The mandate of the Institute is to create human resource of a high calibre to serve the academic institutes and the Indian pharmaceutical industry and the profession, undertake cutting edge research & development in the area of drugs & pharmaceutical and help the Indian pharma industry achieve its goal to become a global player.

Post : Director, NIPER – SAS Nagar (Mohali)

Opportunity to work at Verve HumanCare Laboratories as DRA Executive | walk in

Verve Human Care Laboratories is a pharmaceutical company engaged in Oral Pharmaceuticals Formulation, Granules Pouches & Parenteral. The plant has been designed to meet the requirement of Good Manufacturing Practice as specified by WHO.  The associated persons have rich & valuable experience in the field of medicines, pharmaceuticals,manufacturing, quality control, finance, administration & engineering.

Post : DRA Executive

Walk-in Interview at IPCA for QC, QA, ADL | 30 Openings

Ipca has been continuously evolving as an integrated pharmaceutical company over 65 years. Ipca has an annual turnover in excess of Rs.3,120 Crores with over 350 formulations and 80 APIs for various therapeutic segments. We are committed to Research & Development and expanding our R&D capabilities to build a strong future. cGMP (current Good Manufacturing Practices) & Safety is a way of life. We are committed to further enhance cGMP and safety journey on continuous basis to deliver safe and quality products for mankind and to build a safe workplace for our employees. Our manufacturing facilities of bulk drugs at Ratlam have earned accreditation and approvals from the worlds most vigilant regulatory bodies.

Sun Pharma announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region. The equity consideration for the 85.1% stake is US$ 24 million. Sun Pharma would also assume a debt of approximately US$ 36 million as part of this transaction.